コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rial and the Careful Urinary Tract Infection Evaluation Study).
2 a Study and the African Descent and Glaucoma Evaluation study.
3 a Study and the African Descent and Glaucoma Evaluation Study.
4 ich was found to be 99.9% from a multicenter evaluation study.
5 a Study and the African Descent and Glaucoma Evaluation Study.
6 a Study and the African Descent and Glaucoma Evaluation Study.
7 ed as per the population-based Salisbury Eye Evaluation Study.
8 872 participants in the Japan Gerontological Evaluation Study.
9 rs from the Recipient Epidemiology and Donor Evaluation Study.
10 nors in the Recipient Epidemiology and Donor Evaluation study.
11 trial or the Careful Urinary Tract Infection Evaluation study.
12 rs from the Recipient Epidemiology and Donor Evaluation Study.
13 Cross-discipline evaluation study.
14 a Study and the African Descent and Glaucoma Evaluation Study.
15 a Study and the African Descent and Glaucoma Evaluation Study.
16 a Study and the African Descent and Glaucoma Evaluation Study.
17 e derived from the 2016 Japan Gerontological Evaluation Study.
18 cipating in the Pravastatin Inflammation/CRP Evaluation Study.
19 system, MedLEE, and performed a preliminary evaluation study.
20 join The SARS-CoV-2 Immunity and Reinfection Evaluation study.
21 Comparative diagnostic evaluation study.
22 te-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
23 from the DARE (Drug-Induced Arrhythmia Risk Evaluation) study.
24 w Reserve versus Angiography for Multivessel Evaluation) study.
25 Sonographic Coronary Obstruction Prospective Evaluation) study.
26 ors in Non-Ischemic cardiomyopathy Treatment Evaluation) study.
27 o reference data uncertainty in future model evaluation studies.
28 towards, and using the results from economic evaluation studies.
29 Rs and the radioligand was suitable for drug evaluation studies.
30 eed to be better documented through rigorous evaluation studies.
31 t is, aetiological, longitudinal and service evaluation studies.
32 date reference tests for the conduct of test evaluation studies.
33 ost-exposure vaccination strategies and drug evaluation studies.
34 ls have the potential to enhance preclinical evaluation studies.
35 conducting and interpreting high-quality AI evaluation studies.
36 le of 107 lens images from the Salisbury Eye Evaluation Study, a digital cortical cataract grading al
37 ong participants in the Japan Gerontological Evaluation Study, a population-based cohort study of com
39 (DIGS) and the African Descent and Glaucoma Evaluation Study (ADAGES) were classified with optic dis
40 ma Study (DIGS)/African Descent and Glaucoma Evaluation Study (ADAGES) with >=2 years/4 visits of opt
41 tudy (DIGS)/the African Descent and Glaucoma Evaluation Study (ADAGES) with >=2-years and 4-visit fol
42 90 eyes) enrolled in the African Descent and Evaluation Study (ADAGES) with a diagnosis of glaucomato
43 tudy (DIGS) and African Descent and Glaucoma Evaluation Study (ADAGES) with at least 2 years of follo
44 = 151), and the African Descent and Glaucoma Evaluation Study (ADAGES; validation cohort, n = 52) wer
45 Glaucoma Study-DIGS and African Descent and Evaluation Study-ADAGES) were observed with standard ach
46 e, randomised, open-label, blinded end-point evaluation study, adults with supratentorial ischaemic s
49 SETTING, AND PARTICIPANTS: In this economic evaluation study, an analytical model of drug developmen
50 GN, SETTING, AND PARTICIPANTS: This economic evaluation study analyzed electronic health records link
51 the multicenter African Descent and Glaucoma Evaluation Study and Diagnostic Innovations in Glaucoma
52 g data from the African Descent and Glaucoma Evaluation Study and the Diagnostic Innovations in Glauc
53 sed the control groups of the Asthma Control Evaluation study and the Inner City Anti-IgE Therapy for
54 nt data from the RALES (Randomized Aldactone Evaluation Study) and EMPHASIS-HF (Eplerenone in Mild Pa
57 Renasight Clinical Application, Review, and Evaluation study assessed the utility of genetic testing
64 GN, SETTING, AND PARTICIPANTS: This economic evaluation study, conducted from September 1, 2022, to M
65 main subtomogram classification in extensive evaluation studies demonstrated herein using both simula
66 ons for a standardized approach for economic evaluation study designs (e.g., common asthma outcomes,
69 describe the completed qualitative summative evaluation study, embedded within PALliative Care for en
70 implemented to reduce As exposure, although evaluation studies for these efforts are rare in the lit
71 016, used data from the Japan Gerontological Evaluation Study for participants aged 65 years or older
72 For prostate cancer screening, this economic evaluation study found that PSA testing followed by MRI
73 2010, the HIVE (Household Influenza Vaccine Evaluation) study has followed a cohort of households in
75 [KPNC] and Recipient Epidemiology and Donor Evaluation Study-III [REDS-III] databases of data from J
77 for the 1945-1965 birth cohort, research and evaluation studies in settings where persons who inject
79 GN, SETTING, AND PARTICIPANTS: This economic evaluation study in Massachusetts used a cohort state-tr
80 ed data from the RALES (Randomized Aldactone Evaluation Study) in 1,658 patients with New York Heart
81 ATERIAL/METHODS: This observational clinical evaluation study included 224 patients who were referred
86 to participants in the Japan Gerontological Evaluation Study living in Mifune, a town in Kumamoto Pr
91 ons are intended for tuberculosis diagnostic evaluation studies of symptomatic children with clinical
93 models (Seattle Heart Failure Score, ESCAPE [Evaluation Study of Congestive Heart Failure and Pulmona
94 ndomized or registry portions of the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmona
95 eart failure (n=657) and (2) patients in the Evaluation Study of Congestive Heart Failure and Pulmona
99 ion were created using data from the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmona
100 were measured in 287 patients in the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmona
104 heart failure (HF) patients enrolled in the Evaluation Study of Congestive Heart Failure and Pulmona
106 pective Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab (CARESS) registry was se
107 , registry-based, single-arm, observational, evaluation study of patients with solid cancer and extra
108 SIGN, SETTING, AND PARTICIPANTS: An economic evaluation study of solar-powered O2 was conducted from
110 October 2012 were enrolled in a prospective evaluation study of visual inspection using acetic acid
113 eral design and interpretation of diagnostic evaluation studies, particularly in the field of respira
114 Events in Noncardiac Surgery Patients Cohort Evaluation Study) patients, 735 had available images and
116 ospectively collected, retrospective blinded evaluation study, probability of cancer was calculated f
117 SETTING, AND PARTICIPANTS: In this economic evaluation study, procedure- and diagnosis-specific code
118 D PARTICIPANTS: In this multicenter economic evaluation study, publicly available price transparency
120 fter publication of the Randomized Aldactone Evaluation Study (RALES) in national cohorts of older pa
123 With this report (Randomized Spironolactone Evaluation Study [RALES] trial), we noted a marked incre
124 a With Extremely Serious Operative Mortality Evaluation) study randomized trial and registry of high-
125 HLBI-funded Recipient Epidemiology and Donor Evaluation Study (REDS-III), aims to understand the gene
127 be completed in 2-4 h; and in vitro/in vivo evaluation studies require 1-14 d, depending on the desi
128 is single-institution retrospective economic evaluation study screened 435 patients to identify patie
130 Case studies are presented for 3 vaccine evaluation studies, showcasing some of these challenges
139 n the PREPARE (Primary Prevention Parameters Evaluation) study, these prior strategies were combined
140 SETTING, AND PARTICIPANTS: In this economic evaluation study, time-driven activity-based costing was
141 is typically followed by multisite clinical evaluation studies to confirm diagnostic performance in
142 ue is uniformly accepted and used in vaccine evaluation studies to determine the acceptable level of
143 of commonly used PROMs through psychometric evaluation studies to increase researchers' and clinicia
144 globally commercialized supports use of meta-evaluation studies to test discrimination power among mo
146 l studies in HOPE (Heart Outcomes Prevention Evaluation) study-type patients, the aims of this study
147 GN, SETTING, AND PARTICIPANTS: This economic evaluation study used a 3-state partitioned survival mod
148 GN, SETTING, AND PARTICIPANTS: This economic evaluation study used a microsimulation cohort of patien
149 The diagnostic was assessed in 2 performance evaluation studies using 199 serum samples from individu
153 GN, SETTING, AND PARTICIPANTS: This economic evaluation study was a within-trial cost-effectiveness a
154 GN, SETTING, AND PARTICIPANTS: This economic evaluation study was conducted from a lifetime health ca
160 A-TT first-introducer countries, and several evaluation studies were conducted to estimate the vaccin
163 ucoma Study and African Descent and Glaucoma Evaluation Study were included, based on the appearance
165 ne thousand participants enrolled in a field evaluation study, were linked to population-level health
166 a Study and the African Descent and Glaucoma Evaluation Study with >=2 years/5 visits of optic nerve
167 n the multisite African Descent and Glaucoma Evaluation Study with primary open-angle glaucoma and wh